From: Chidamide, decitabine, cytarabine, aclarubicin, and granulocyte colony-stimulating factor (CDCAG) in patients with relapsed/refractory acute myeloid leukemia: a single-arm, phase 1/2 study
Clinical response
N (%)
CR
24 (25.8)
CRi
19 (20.4)
PR
8 (8.6)
NR
38 (40.9)
ED
4 (4.3)